Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Woolf

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The British Journal of Dermatology|September 5, 2024
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024Michael R Ardern-Jones, Sara J Brown, Carsten Flohr, et al.
BMJ Open|October 10, 2025
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasisWeiyu Ye, Kingsley Powell, Niamh Dooley, et al.
The British Journal of Dermatology|January 29, 2025
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohortElizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
The British Journal of Dermatology|August 19, 2021
Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)S Cro, V R Cornelius, A E Pink, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The British Journal of Dermatology|September 5, 2024
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024Michael R Ardern-Jones, Sara J Brown, Carsten Flohr, et al.
BMJ Open|October 10, 2025
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasisWeiyu Ye, Kingsley Powell, Niamh Dooley, et al.
The British Journal of Dermatology|January 29, 2025
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohortElizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
The British Journal of Dermatology|August 19, 2021
Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)S Cro, V R Cornelius, A E Pink, et al.
Pageof 5